Drug eluting stents are safe for licensed indications, FDA panel says.
作者信息
Mayor Susan
出版信息
BMJ. 2006 Dec 16;333(7581):1235. doi: 10.1136/bmj.39063.481285.DB.
Abstract
摘要
相似文献
1
Drug eluting stents are safe for licensed indications, FDA panel says.美国食品药品监督管理局专家小组称，药物洗脱支架在获批适应症方面是安全的。
BMJ. 2006 Dec 16;333(7581):1235. doi: 10.1136/bmj.39063.481285.DB.
2
3
Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring--FDA. Proposed rule.用于诊断和监测的体内放射性药物法规——美国食品药品监督管理局。拟议规则。
Fed Regist. 1998 May 22;63(99):28301-9.
4
Therapeutic monoclonal antibodies: trends in development and approval in the US.治疗性单克隆抗体：美国的研发与获批趋势
Curr Opin Mol Ther. 2002 Apr;4(2):110-8.
5
Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.药物洗脱支架研发面临的监管问题：美国食品药品监督管理局的观点
Expert Rev Med Devices. 2006 May;3(3):297-300. doi: 10.1586/17434440.3.3.297.
6
7
The FDA and "privatization"--the drug approval process.美国食品药品监督管理局与“私有化”——药物审批程序
Food Drug Law J. 1995;50 Spec:203-25.
8
FDA notifications. FDA approves lipidatrophy drug.美国食品药品监督管理局通知。美国食品药品监督管理局批准脂肪萎缩药物。
AIDS Alert. 2007 Mar;22(3):31.
9
10
FDA notifications. FDA grants tentative approval to generic Nevirapine.美国食品药品监督管理局通知。美国食品药品监督管理局暂时批准奈韦拉平仿制药。
AIDS Alert. 2006 Feb;21(2):23-4.
引用本文的文献
1
Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease.服用抗血小板药物治疗心血管疾病的患者行经尿道膀胱肿瘤切除术的风险和并发症。
Surg Endosc. 2014 Jan;28(1):116-21. doi: 10.1007/s00464-013-3136-8. Epub 2013 Sep 4.
2
Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.药物洗脱支架置入术后双联抗血小板治疗患者早期行搭桥治疗。
Neth Heart J. 2011 Oct;19(10):412-7. doi: 10.1007/s12471-011-0197-y.
3
Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy.接受双联血小板抗聚集治疗患者的膀胱癌内镜切除术。
Surg Endosc. 2011 Jul;25(7):2281-7. doi: 10.1007/s00464-010-1549-1. Epub 2011 Feb 8.
4
The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use.无论使用药物洗脱支架还是裸金属支架，“非适应证”支架植入术后确定性支架血栓形成风险都会增加。
Clin Res Cardiol. 2009 Sep;98(9):549-54. doi: 10.1007/s00392-009-0039-8. Epub 2009 Aug 11.
Zotero 插件